Category: Prevalence/Incidence

All Podcast Categories
S3-E39.5 - From The Vault: Early, Accurate Patient Information Matters

S3-E39.5 – From The Vault: Early, Accurate Patient Information Matters

In this conversation from September 2021, Anthony Villiotti of NASH kNOWledge joins Louise Campbell and Roger Green to discuss his “biggest story of the summer:” two publications, on demonstrating that NASH prevalence and incidence may be far higher than we believe and another demonstrating how limited public knowledge about NASH is today.

S3-E30.1 - Highlighting Intriguing ILC2022 Abstracts: Machine Learning Identified NASH Biomarkers and a Cost-Effectiveness Study

S3-E30.1 – Highlighting Intriguing ILC2022 Abstracts: Machine Learning Identified NASH Biomarkers and a Cost-Effectiveness Study

Stephen Harrison, Jörn Schattenberg, Louise Campbell and Roger Green identify some of what they believe will be key papers at 3ILC2022. This conversation focuses on OS 097, which uses LITMUS Metacohort Data to identify the biomarkers that predict each of the four element of the NASH score best and FRI094, a study that evaluates the cost of community-based NAFLD screening for Type 2 Diabetes patients.

S3-E30 - Previewing #ILC2022: Focus on NITs and Patients

S3-E30 – Previewing #ILC2022: Focus on NITs and Patients

Jörn Schattenberg, Stephen Harrison, Louise Campbell and Roger Green discuss some of the most striking and important Fatty Liver-related abstracts to be presented at next week’s #ILC2022 meeting in London. Some key drug development papers are embargoed, but there were plenty of important works on NITs, quality-of-life and general patient issues for the group to discuss.

S3-E29 - #NASHDay 2022: SurfingNASH Wrap-Up

S3-E29 – #NASHDay 2022: SurfingNASH Wrap-Up

The SurfingNASH team (Jörn Schattenberg, Louise Campbell, Roger Green) join Global Liver Institute NASH Programs Director Jeff McIntyre for the wrap-up panel of #NASHDay 2022.

S3-E25.6 - Emerging Concepts In NASH: NAFLD Patient Screening, NASH Management

S3-E25.6 – Emerging Concepts In NASH: NAFLD Patient Screening, NASH Management

Surfing the NASH Tsunami shares Dr. Marcelo Kugelmas’s portion of the Madrigal Pharmaceuticals presentation at NAFLD, which covers NAFLD patient screening and diagnostics along with NASH patient management. After this, he answers questions from Roger Green, who then interviews Dr. Naim Alkhouri on disease prevalence and strategies for bringing patient to be tested.

Experience Nudge Learning!
Interested in a new way of learning?